0

Richard Davis | PHD

Rick joined Nouscom in September 2020 from Johnson and Johnson Innovation where he was the Global Oncology Venture and Transaction Lead. He was Chief Executive Officer of a European clinical [...]

0

Göran Ando | MD

Göran has more than 35 years of leadership and management experience in the biotech and pharmaceutical industry, with Board positions at several global companies, including currently as Chairman [...]

0

Loredana Siani | PHD

Loredana recently joined Nouscom as the Technical Director from Reithera. She has fifteen years of industry experience spanning process development and GMP production of viral vectored vaccines. [...]

0

Patricia Delaite | MD

Patricia joined Nouscom in January 2020 as Chief Medical Officer from AMAL Therapeutics where she acted as CMO. Prior to AMAL, Patricia spent 15 years in biopharmaceutical clinical development, [...]

0

Nouscom Strengthens its Management Team

Marina Udier, PhD, appointed as Chief Executive Officer and Patricia Delaite, MD, appointed as Chief Medical Officer BASEL, Switzerland – 26. February 2020: Nouscom, an immuno-oncology company [...]